Search Within

Lee M Krug

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (8)
Groups
  1. Advanced Practice Providers (17)
  2. Department of Medicine (17)
  3. Nursing (16)
  4. Solid Tumor Oncology Division (16)
  5. Thoracic Oncology (15)
  6. Survivorship Research (11)

More Groups

People
  1. Mark Kris (15)
  2. Christopher Azzoli (12)
  3. Megan Dunne (10)
  4. Vincent Miller (10)
  5. Leslie Tyson (9)
  6. Naiyer Rizvi (8)

More People

Years
  1. 2014 (1)
  2. 2012 (2)
  3. 2011 (2)
  4. 2010 (1)
  5. 2009 (1)
  6. 2008 (2)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Clinical Cancer Research (3)
  3. Journal of Thoracic Oncology (3)
  4. Cancer (2)
  5. Cancer Immunology, Immunotherapy (1)
  6. Lung Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (4)
  3. Elsevier Inc. (3)
  4. Wiley Blackwell (2)
  5. Elsevier Ireland Ltd. (1)
  6. Springer (1)

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase
    Journal Article

    Zauderer, M. G.; Drilon, A.; Kadota, K.; Huberman, K.; Sima, C. S.; Bergagnini, I.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; more...
    Lung Cancer (2014)

    Fulltext@MSK | Save
  • 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial
    Meeting Abstract

    Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker
    Journal Article

    Pietanza, M. C.; Kadota, K.; Huberman, K.; Sima, C. S.; Fiore, J. J.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; Holodny, A. I.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations
    Meeting Abstract

    D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
    Journal Article

    Krug, L. M.; Dao, T.; Brown, A. B.; Maslak, P.; Travis, W.; Bekele, S.; Korontsvit, T.; Zakhaleva, V.; Wolchok, J.; Yuan, J.; more...
    Cancer Immunology, Immunotherapy (2010)

    Fulltext@MSK | Save
  • Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Meeting Abstract

    Pietanza, M. C.; Pereira, L.; Dunne, M.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Pilot trial of a Wilms tumor-1 (WT1) peptide vaccine in patients with thoracic and myeloid neoplasms
    Meeting Abstract

    Brown, A. B.; Krug, L. M.; Maslak, P.; James, L. P.; Dao, T.; Tyson, L.; Chanel, S. M.; Bekele, S.; Scheinberg, D. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Activity of XL647 in clinically selected NSCLC patients (pts) enriched for the presence of EGFR mutations: Results from Phase 2
    Meeting Abstract

    Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Krug, L. M.; Bekele, S.; Dowlati, A.; Rowland, K. M.; Salgia, R.; Aggarwal, N.; Gadgeel, S. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    James, L. P.; Azzoli, C. G.; Krug, L. M.; Miller, V.; Tripathi, P.; Subzwari, S.; Tyson, L. B.; Dunne, M.; Huntington, M. F.; Saunders, M. E.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save